Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about ALPMY

Recent news which mentions ALPMY

< Previous 1 2 Next >
Super Bowl Commercials 2023: The Complete List Of Super Bowl LVII Ads And The Companies Behind Them
Tickers ALPMY AMZN BKNG BUD
Tags Nick Jonas VZ DKNG
From Benzinga
Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts
Tickers ALPMF ALPMY HZNP SELB
Tags ALPMF Price Target General
From Benzinga
Sandoz Acquires Antifungal Agent From Astellas, Reinforcing Hospital Offering
Tickers ALPMF ALPMY GSK NVS
Tags Briefs Biotech Large Cap
From Benzinga
What Is Going on With Taysha Gene (TSHA) Stock Today?
Tickers ALPMY TSHA
Tags TSHA Market News NASDAQ:TSHA,OTCMKTS:ALPMY
From InvestorPlace
Astellas Pharma Invests $50M To Support Taysha's Gene Therapy Programs
Tickers ALPMF ALPMY TSHA
Tags Market News why it's moving ALPMY
From Benzinga
Astellas' Menopause Drug Under FDA Review
Tickers ALPMF ALPMY
Tags Biotech Briefs ALPMF
From Benzinga
Seagen Shares Jump On Positive Data From Urothelial Cancer Trial
Tickers ALPMF ALPMY MRK SGEN
Tags Trading Ideas Movers Health Care
From Benzinga
7 Best Biotech Stocks to Buy in July 2022
Tickers AAPL ALPMY AMGN AZN
Tags AAPL TWST MRNA
From InvestorPlace
Sutro Biopharma Stock Surges On Cancer Treatment Pact
Tickers ALPMF ALPMY STRO
Tags Briefs Biotech Penny Stocks
From Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
Tickers ALPMF ALPMY AXSM AZN
Tags BNTX AXSM ALPMF
From Benzinga
Astellas's Pompe Disease Gene Therapy Trial Put On FDA Clinical Hold
Tickers ALPMF ALPMY
Tags News FDA ALPMY
From Benzinga
Twist Bioscience, Astellas Join Forces To Develop Cancer Targeting Antibodies
Tickers ALPMF ALPMY TWST
Tags General ALPMF Market News
From Benzinga
Astellas - Seagen's Padcev Approved In Europe For Most Common Form Of Bladder Cancer
Tickers ALPMF ALPMY SGEN
Tags ALPMF General SGEN
From Benzinga
Astellas' Menopause Drug Suffers Setback After Failed Asian Trial
Tickers ALPMF ALPMY
Tags Market News Health Care ALPMY
From Benzinga
Got $1,000? Here's a Dirt-Cheap Big Pharma Stock to Buy
Tickers ALPMY BMY BNTX JNJ
Tags JNJ Market News PFE
From Motley Fool
Astellas Touts Safety Data For Phase 3 Menopause Drug, Sets Up US Filing
Tickers ALPMF ALPMY
Tags News ALPMY Health Care
From Benzinga
Astellas Pharma - Seagen's Enfortumab Shows 36% Pathologic Complete Response In Bladder Cancer Patients
Tickers ALPMF ALPMY SGEN
Tags Market News News ALPMY
From Benzinga
Here's Why Biotech Stocks Adaptimmune Therapeutics, Agenus, and Ocugen All Crashed in November
Tickers ADAP AGEN ALPMY GSK
Tags XBI OCGN GSK
From Motley Fool
Gene Therapy-Focused Dyno Therapeutics Adds Astellas To List Partner List With $1.6B Pact
Tickers ALPMF ALPMY NVS RHHBF
Tags Health Care Movers RHHBY
From Benzinga
Astellas Pharma's Bladder Cancer Treatment Scores Approval In Japan
Tickers ALPMF ALPMY
Tags Health Care Market News News
From Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
Tickers ABT ACAD ADGI ALPMY
Tags NRXP Biotech ZNTL
From Benzinga
Astellas' Gene Therapy Trial Hit With Another Death, FDA Slaps Clinical Hold
Tickers ALPMF ALPMY
Tags Market News Health Care ALPMY
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
Tickers ACIU ADGI ALKS ALPMY
Tags BHVN BBI WST
From Benzinga
See Why Astellas Stopped Dosing In Neuromuscular Disease Gene Therapy Trial
Tickers ALM ALPMF ALPMY
Tags Market News Health Care ALPMY
From Benzinga
After FDA Rejection, EMA Approves FibroGen-Astellas' Roxadustat
Tickers AKBA ALPMF ALPMY AZN
Tags Briefs Biotech Long Ideas
From Benzinga
Here's What Recent News From the FDA Means for AstraZeneca
Tickers ALPMY AZN FGEN
Tags FGEN Market News AZN
From Motley Fool
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Tickers ABVC ACAD ACET ADMA
Tags ALPMY KNTE BLUE
From Benzinga
FibroGen Shares Are Trading Lower As FDA Shoots Down Roxadustat Application, Asks For Additional Trial
Tickers ALPMF ALPMY AZN FGEN
Tags Chronic Kidney Disease Short Ideas Movers
From Benzinga
Why Investors Should Like BioNTech's Latest Deal With Gilead
Tickers ALPMY BNTX GILD PFE
Tags BNTX ALPMY GILD
From Motley Fool
The IPO Recap – Party Is Everything But Over
Tickers ABSI ALPMY BASE CNM
Tags ZENV OB ABSI
From Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.